Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Toxicol Res ; 36(1): 89-98, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31998628

ABSTRACT

Cynanchi wilfordii Radix (CWR) is a herbal medicinal plant that is well-known and used in Asian countries as a health food. In this study, acute and 13-week subchronic oral toxicity studies of hot-water extract of CWR (CWR-WE) were performed in Sprague-Dawley rats. For the acute toxicity study, CWR-WE was administered once orally to five male and five female rats at doses of 800, 2000, and 5000 mg/kg. Mortality, clinical signs, and body weight changes were monitored over 14 days. There were no treatment-related changes in these parameters and the approximate lethal dose of CWR-WE in male and female rats was determined to be > 5000 mg/kg. For the subchronic toxicity study, CWR-WE was administered orally once daily to male and female rats for 13 consecutive weeks at doses of 0 (vehicle control), 500, 1000, and 2000 mg/kg/day (n = 10 rats/sex/group). There were no toxicologically significant changes with regard to clinical signs, body weight, food consumption, ophthalmology, urinalysis, hematology, clinical chemistry, organ weights, necropsy findings, and histopathological findings. These results suggest that the oral no observed adverse-effect level of CWR-WE is > 2000 mg/kg/day for both sexes, although target organs were not identified.

2.
Toxicol Rep ; 4: 9-18, 2017.
Article in English | MEDLINE | ID: mdl-28959620

ABSTRACT

A 90-day oral toxicity study of γ-oryzanol, a rice-derived triterpenoid ferulate, was performed by oral gavage administration to male and female Sprague-Dawley rats at doses of 0, 1000, and 2000 mg/kg body weight/day. All rats administered γ-oryzanol survived throughout the study period. Both male and female rats showed no toxicologically significant changes of the general signs, examination findings, body weight, food consumption, functional observational battery results, ophthalmological findings, urinalysis, hematology tests, clinical chemistry tests, organ weights, and necropsy findings. Moreover, there were no histopathological changes related to administration of γ-oryzanol in males and females from the 2000 mg/kg body weight/day group. In conclusion, the no observed adverse effect level (NOAEL) of γ-oryzanol exceeded 2000 mg/kg body weight/day for both male and female rats under the conditions of this study.

3.
Toxicol Res ; 33(1): 15-23, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28133509

ABSTRACT

Acanthopanax divaricatus (Siebold & Zucc.) Seem. var. albeofructus (ADA), a traditional medical herb, has been used to treat arthritis and muscular injury, to strengthen muscle and bone, and to get vital energy. However, information regarding its toxicity is limited. ADA was administered by oral gavage to groups of rats at doses of 0 (control), 1,000, 1,500, 2,000, 2,500, and 3,000 mg/kg five times per week for 13 weeks. Mortality, clinical signs, body weights, food consumption, hematology, serum chemistry, urinalysis, organ weights, necropsy, histopathological finding, vaginal cytology, and sperm morphology were compared between control and ADA-treated groups. Salivation was intermittently observed in both sexes receiving 2,500 and 3,000 mg/kg directly after dosing. Absolute liver weights increased in females receiving 2,000, 2,500, and 3,000 mg/kg ADA (P < 0.05, P < 0.01, and P < 0.01, respectively) and so did the relative liver weights (P < 0.001). Salivation and increased liver weight were ADA-related changes but not considered to be adverse effects. Salivation was intermittent and transient, and the liver weight increase was minor and not accompanied by other changes such as hepatic morphological or functional alterations. The no-observed-adverse-effect-level was determined to be at least 3,000 mg/kg in both sexes of rats.

4.
J Ethnopharmacol ; 183: 46-53, 2016 May 13.
Article in English | MEDLINE | ID: mdl-26924566

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Acorus gramineus rhizoma (AGR) is the dry rhizome of Acorus gramineus Solander from the family Araceae that has been used as sedative, analgesic, diuretic, digestive and antifungal agent. AIM OF THE STUDY: To evaluate the no-observed-adverse-effect level (NOAEL) and the toxicity of AGR, following repeated oral administration to rats for 13 weeks. MATERIALS AND METHODS: AGR was administered by oral gavage to groups of rats (10 per group, each sex) at doses of 0 (control), 25, 74, 222, 667, or 2,000mg/kg/day, 5 times per week for 13 weeks. Mortality, clinical signs, body weights, food consumption, hematology, serum chemistry, urinalysis, vaginal cytology, sperm motility, sperm morphology, organ weights, gross and histopathological findings were compared between control and AGR groups. RESULTS: No mortality or remarkable clinical signs were observed during this 13-week study. No adverse effects on body weight, food consumption, urinalysis, hematology, serum chemistry, organ weights, gross lesion, histopathology, vaginal cytology, sperm motility or deformity were observed in any of the male or female rats treated with AGR. CONCLUSIONS: On the basis of these results, the NOAEL of AGR is determined to be 2,000mg/kg/day for male and female rats.


Subject(s)
Acorus/adverse effects , Acorus/chemistry , Plant Extracts/adverse effects , Plant Extracts/pharmacology , Rhizome/adverse effects , Rhizome/chemistry , Administration, Oral , Animals , Body Weight/drug effects , Female , Male , No-Observed-Adverse-Effect Level , Organ Size/drug effects , Plant Extracts/chemistry , Rats , Sperm Motility/drug effects
5.
J Ethnopharmacol ; 152(3): 457-63, 2014 Mar 28.
Article in English | MEDLINE | ID: mdl-24486210

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Coptidis Rhizoma (CR) is a medical herb from the family Ranunculacease that has been used to treat gastroenteritis, dysentery, diabetes mellitus, and severe skin diseases. AIM OF THE STUDY: To evaluate the no-observed-adverse-effect level (NOAEL) and the toxicity of CR, following repeat oral administration to rats for 13 weeks. MATERIALS AND METHODS: CR was administered by oral gavage to groups of rats (n=10/group, each sex) at dose levels of 0 (control), 25, 74, 222, 667 or 2000 mg/kg/day 5 times per week for 13 weeks. Mortality, clinical signs, body weights, food consumption, hematology, serum chemistry, urinalysis, vaginal cytology and sperm morphology, organ weights, gross and histopathological findings were compared between control and CR groups. RESULTS: Urinalysis showed a significant increase in N-acety1-ß-glucosaminidase in males in the 2000 mg/kg/day group (P<0.01). However, no mortality or remarkable clinical signs were observed during this 13-week study. No adverse effects on body weight, food consumption, hematology, serum chemistry, organ weights, gross lesion, histopathology, vaginal cytology, sperm motility, or deformity were observed in the males or female rats treated with CR. CONCLUSIONS: On the basis of these results, the NOAEL of CR is determined to be 667 mg/kg/day for males and 2000 mg/kg/day for females.


Subject(s)
Acetylglucosaminidase/metabolism , Drugs, Chinese Herbal/toxicity , Administration, Oral , Animals , Body Weight/drug effects , Coptis chinensis , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/administration & dosage , Female , Male , No-Observed-Adverse-Effect Level , Organ Size/drug effects , Rats , Rats, Inbred F344 , Sex Factors , Toxicity Tests, Subchronic
6.
J Ethnopharmacol ; 151(3): 1072-1078, 2014 Feb 12.
Article in English | MEDLINE | ID: mdl-24384379

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Evodia, a fruit from Evodia rutaecarpa, has been used in oriental medicine, and since its various pharmaceutical actions, including anti-cancer activity, have become known, evodia has been widely used as a dietary supplement. However, information regarding its toxicity is limited. MATERIALS AND METHODS: Evodia fruit from Evodia rutaecarpa (Juss.) Benth. var. officinalis (Dode) Huang (0, 25, 74, 222, 667, and 2000 mg/kg) was administered orally five times per week for 13 weeks. Clinical signs, body weight, food consumption, hematology, serum chemistry, urinalysis, vaginal cytology, sperm morphology, organ weight, and gross and histopathological findings were evaluated. RESULTS: Urinary ketone body excretion was detected in males at 667 and 2000 mg/kg and in females at 2000 mg/kg. An increase in absolute/relative liver weight was observed in both sexes at 2000 mg/kg. Although levels of serum alanine aminotransferase, glucose, total cholesterol, and triglycerides were significantly reduced in males and/or females at 200 and/or 667 and 2000 mg/kg, all values were within normal ranges and were considered non-adverse. In addition, no treatment-related differences in body weight, food consumption, hematology, vaginal cytology, sperm morphology, or gross and histopathological examination were detected. CONCLUSIONS: The subchronic no-observable-adverse-effect level for evodia fruit powder following oral administration in rats is greater than 2000 mg/kg.


Subject(s)
Evodia , Plant Preparations/toxicity , Animals , Female , Fruit , Male , No-Observed-Adverse-Effect Level , Powders , Rats , Rats, Inbred F344 , Toxicity Tests, Subchronic
7.
Toxicol Res ; 30(4): 305-9, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25584151

ABSTRACT

Recently, there has been an increase in the use of several nephrotoxicity biomarkers in preclinical experiments. In addition, it has been indicated that the result may have been influenced by secondary factors, such as sample storage condition or storage period. In this study, we have assessed the variation in urinary nephrotoxicity biomarkers as a result of urine storage conditions and storage period of the urine. Urine was sampled from specific pathogen-free Sprague-Dawley rats (19 weeks old), which were housed individually in hanged stainless steel wire mesh cages. Urine was stored at 20℃, at 4℃, or at -70℃ after sampling. The levels of the biomarkers such as beta-2 microglobulin (B2M), cystatin-C (Cys-C), N-acetyl-ß- D-glucosaminidase (NAG), micro albumin (MA), micro protein (MP) were measured at 6, 24, 48 and 144 hr after sampling. The B2M level was significantly decreased at 6, 24, 48, and 144 hr compared to 0 hr at -70℃ (p < 0.05, p < 0.01, p < 0.05, and p < 0.05, respectively) and 24 and 144 hr at 20℃ (p < 0.01, p < 0.01, respectively). The Cys-C level was significantly decreased at 144 hr compared to 0 hr at 4℃ (p < 0.01), at 20℃ (p < 0.05) and at 70℃ (p < 0.01). MP and MA levels were not different for 144 hr in all storage conditions. Taken together, B2M and Cys-C levels were modulated by storage temperature and period. For the enhancement of test accuracy, it is suggested that strict protocols be established for samples to minimize the effects of the storage conditions on the detected levels of biomarkers.

8.
Environ Health Toxicol ; 29: e2014024, 2014.
Article in English | MEDLINE | ID: mdl-25622643

ABSTRACT

OBJECTIVES: The sub-acute toxic effects following repetitive intramuscular injection of two cervical cancer vaccines newly developed against human papillomaviruse (HPV)16/58/18 and HPV16 were investigated in female ICR (CrljOri: CD1) mice, and the no-observedadverse- effect-level (NOAEL) of the cervical cancer vaccines was estimated. METHODS: Female ICR mice (n=15 in each group) were exposed to a 1:1 mixture of two cervical cancer vaccines by repetitive intramuscular injection (once a week, 5 times) for 5 weeks. Mortality, body weight, organ weight, hematological/biochemical parameters, and histopathological effects were examined at different concentrations (0, 1×10(8), 5×10(8), and 2.5×10(9) copies/animal) of the cervical cancer vaccines. RESULTS: The cervical cancer vaccines did not show toxic responses for body weight, absolute/ relative organ weight, hematological/biochemical parameters, or histopathological parameters. CONCLUSIONS: Female ICR mice exposed to vaccines for cervical cancer did not show any toxic response. We suggest that a NOAEL of the vaccine following repetitive intramuscular injection for 5 weeks is >2.5×10(9) copies/animal.

9.
Exp Toxicol Pathol ; 65(5): 631-6, 2013 Jul.
Article in English | MEDLINE | ID: mdl-22884259

ABSTRACT

A small cardiac tumor was detected in the posterior wall of the left atrium of a 110-week-old female Wistar Hannover rat (Slc: Wistar Hannover/Rcc) during a carcinogenicity historical control study. Tumor was consisted of 2 different cells. Most of the tumor cells were polygonal to oval in shape and had slightly basophilic and granular cytoplasm. These cells were arranged in distinctive cell nests, called 'Zellballen', and were separated by reticulin fibers. The nuclei were round to slightly oval. A few mitotic figures were found. Cytoplasmic granules of tumor cells were negative for Fontana-Masson and Periodic acid Schiff (PAS) staining. Immunohistochemical staining revealed that the chief cells in the tumor were positive for the neuroendocrine markers synaptophysin and chromogranin A but were negative for S-100 protein, vimentin, cytokeratin, α-smooth muscle actin, and calcitonin. In contrast, the surrounding sustentacular cells, other type of tumor cells, were positive for only S-100 protein. The immunohistochemical properties of the tumor cells were quite similar to those of the aortic body. The tumor cells had infiltrated the myocardium of the left atrium and were also noted within vessels. Based on these findings, the tumor was diagnosed as a paraganglioma originating from the aortic body.


Subject(s)
Aorta/pathology , Biomarkers, Tumor/metabolism , Heart Atria/pathology , Heart Neoplasms/pathology , Paraganglioma/pathology , Animals , Aorta/metabolism , Chromogranin A/metabolism , Cytoplasmic Granules/metabolism , Cytoplasmic Granules/pathology , Female , Heart Atria/metabolism , Heart Neoplasms/metabolism , Immunohistochemistry , Paraganglioma/metabolism , Rats , Rats, Inbred Strains , Synaptophysin/metabolism
10.
Regul Toxicol Pharmacol ; 64(2): 253-62, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22885075

ABSTRACT

Interleukin-2 (IL-2) is a lymphokine with a potential role in cancer therapy. Many clinical trials of recombinant human IL-2 (rhIL-2) have been conducted to treat malignant renal carcinoma, melanoma, leukemia, lymphoma, multiple myeloma. BMI Korea has developed a method to manufacture rhIL-2 in bulk using Escherichia coli as a biosimilar. Prior to conducting human clinical trials, 4-week repeated toxicity study of rhIL-2 was conducted. In this study, rhIL-2 was administered intravenously to rats at doses of 9×10(6), 18×10(6), and 36×10(6)IU/kg/day over a period of 4 weeks. Adverse effects were observed in RBC, HGB, HCT, reticulocyte, mesenteric lymph node from middle dose, and changes of total bilirubin, femoral bone marrow, thymus, and clinical signs were observed at high dose. Local irritation was determined at low dose of female rats and at middle dose of male ones. Taken together, no observed adverse effect levels (NOAEL) was determined at dose of 9×10(6)IU/kg/day in male, and NOAEL was determined under the dose level in female rats. It suggests that present rhIL-2 is less toxic prior produced rhIL-2 and may be contribute more effective cancer-treatment strategy in human.


Subject(s)
Interleukin-2/toxicity , Administration, Intravenous , Animals , Drug Evaluation, Preclinical , Female , Humans , Interleukin-2/administration & dosage , Interleukin-2/pharmacokinetics , Male , No-Observed-Adverse-Effect Level , Rats , Rats, Sprague-Dawley , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacokinetics , Recombinant Proteins/toxicity , Therapeutic Equivalency , Toxicity Tests, Subacute
11.
Res Vet Sci ; 92(3): 486-91, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21592537

ABSTRACT

The expression patterns of different secreted (MUC2, MUC5AC, MUC5B, and MUC6) and membrane-bound (MUC4) mucins were determined immunohistochemically in the lungs of pigs experimentally infected with Actinobacillus pleuropneumoniae. Forty-seven-week-old colostrum-deprived pigs were randomly allocated to infected (n=20) or control groups (n=20). Five infected and uninfected pigs were euthanized at 0, 6, 12, and 48 h post-inoculation (hpi). In the infected pigs, the expression of both types of mucins, which were invariably observed, was associated with bronchiolar and respiratory bronchiolar lesions. Strong positive mucin signals were seen on the surface of bronchiolar and respiratory bronchiolar epithelium with neutrophil infiltration. The mean mucin-positive area peaked at 6 hpi and decreased significantly to control levels by 48 hpi on the surface of the bronchiolar and respiratory bronchiolar epithelium. Further studies are needed to establish the functional relationship between mucin expression and the host defense mechanism against A. pleuropneumoniae in the lungs of infected pigs.


Subject(s)
Actinobacillus Infections/veterinary , Actinobacillus pleuropneumoniae , Lung/metabolism , Mucins/metabolism , Pneumonia, Bacterial/veterinary , Swine Diseases/metabolism , Actinobacillus Infections/immunology , Actinobacillus Infections/metabolism , Animals , Gene Expression Regulation/immunology , Lung/microbiology , Mucins/genetics , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/pathology , Respiratory Mucosa/metabolism , Swine , Swine Diseases/immunology , Swine Diseases/microbiology , Time Factors
12.
Can J Vet Res ; 76(3): 195-200, 2012 Jul.
Article in English | MEDLINE | ID: mdl-23277698

ABSTRACT

An optimized protocol was developed for the simultaneous detection and differentiation of Haemophilus parasuis, Streptococcus suis, and Mycoplasma hyorhinis in formalin-fixed, paraffin-embedded (FFPE) tissues with multiplex nested polymerase chain reaction (PCR). This method also determines the prevalence of these bacteria in pigs with polyserositis. DNA extraction with a combination of a commercial reagent and proteinase K resulted in more frequent detection of the pathogens than DNA extraction with proteinase K alone. Among FFPE tissue samples from 312 cases of polyserositis in which at least 1 bacterial species was detected, multiplex nested PCR detected H. parasuis in 239 (77%), S. suis in 124 (40%), and M. hyorhinis in 40 (13%). The disease was caused by a single pathogen in 224 (72%) of the cases and multiple pathogens in 88 (28%). Among the pigs positive for H. parasuis, S. suis, and M. hyorhinis by multiplex nested PCR, the pathogen was isolated from only 11%, 35%, and 28%, respectively. Therefore, the PCR protocol developed in this study is a useful diagnostic method when samples are negative after isolation methods and even for samples in which only 1 pathogen was isolated.


Subject(s)
Haemophilus parasuis/isolation & purification , Multiplex Polymerase Chain Reaction/veterinary , Mycoplasma hyorhinis/isolation & purification , Serositis/veterinary , Streptococcus suis/isolation & purification , Swine Diseases/microbiology , Animals , Formaldehyde , Haemophilus Infections/microbiology , Haemophilus Infections/veterinary , Multiplex Polymerase Chain Reaction/methods , Mycoplasma Infections/microbiology , Mycoplasma Infections/veterinary , Paraffin Embedding , Sensitivity and Specificity , Serositis/microbiology , Streptococcal Infections/microbiology , Streptococcal Infections/veterinary , Swine , Swine Diseases/diagnosis , Tissue Fixation
13.
Clin Vaccine Immunol ; 18(7): 1091-6, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21613465

ABSTRACT

The objective of the present study was to determine the effect of an inactivated porcine circovirus type 2 (PCV2) vaccine on PCV2b virus shedding in the semen of experimentally infected boars by measuring the immunological response and the PCV2b DNA load in blood and semen. Twelve boars were randomly divided into three groups. The boars in group 1 (n = 4) were immunized with an inactivated PCV2 vaccine and were challenged with PCV2b. The boars in group 2 (n = 4) were only challenged with PCV2b. The boars in group 3 (n = 4) served as negative controls. The number of PCV2 genome copies of PCV2 in the serum and semen were significantly lower in vaccinated challenged boars than in nonvaccinated challenged boars at 7, 10, 14, 21, 32, 35, 42, 49, and 60 days postinoculation. The number of PCV2b genomes in the semen correlated with the number of PCV2b genomes in the blood in both vaccinated challenged (R = 0.714) and nonvaccinated challenged (R = 0.861) boars. The results of the present study demonstrate that the inactivated PCV2 vaccine significantly decreases the amount of PCV2b DNA shedding in semen from vaccinated boars after experimental infection with PCV2b.


Subject(s)
Circovirus/immunology , Semen/virology , Vaccines, Inactivated/pharmacology , Virus Shedding/drug effects , Animals , DNA, Viral/analysis , DNA, Viral/drug effects , Genome, Viral/drug effects , Immunization , Male , Swine
14.
Vet Res Commun ; 35(4): 255-60, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21331513

ABSTRACT

The aim of this study was to determine the immunoreactivity of normal small bronchial, bronchiolar, respiratory bronchiolar, and interalveolar epithelium using antibodies to six mucins: MUC1, MUC2, MUC4, MUC5AC, MUC5B, and MUC6. The large, gel-forming secreted mucins MUC2, MUC5AC, and MUC5B were widely expressed in the lower respiratory tract. The results of this study demonstrate that these secreted mucins form a gel to cover and protect the mucosal surface in the lower respiratory tract of pigs.


Subject(s)
Bronchi/metabolism , Mucins/metabolism , Mucous Membrane/metabolism , Pulmonary Alveoli/metabolism , Sus scrofa/immunology , Animals , Animals, Suckling , Gene Expression Profiling , Sus scrofa/metabolism
15.
Eur J Pharm Biopharm ; 77(1): 36-42, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20932903

ABSTRACT

Chitosan has been proposed as a non-viral gene carrier because of its biodegradable and biocompatible cationic polymeric properties. However, the transfection efficiency of chitosan-DNA complexes is still too low for clinical trials. To improve transfection efficiency, we prepared a chitosan-graft-spermine (CHI-g-SPE) copolymer by an imine reaction between periodate-oxidized chitosan and spermine. The CHI-g-SPE copolymer was complexed with plasmid DNA in various copolymer-DNA weight ratios, and the complexes were characterized. The CHI-g-SPE copolymer showed good DNA binding ability and high protection of DNA from nuclease attack. The CHI-g-SPE/DNA complexes had well-formed spherical shapes and a nanoscale size with homogenous size distribution. The CHI-g-SPE copolymer had low cytotoxicity and CHI-g-SPE/DNA complexes showed transfection efficiency that was enhanced over that of chitosan-DNA. Furthermore, aerosol delivery of CHI-g-SPE/GFP complexes showed higher GFP expression compared with chitosan/GFP complexes, without toxicity. Our results indicate that the CHI-g-SPE copolymer has potential as a gene carrier.


Subject(s)
Chitosan/chemistry , Gene Transfer Techniques , Polymers/chemical synthesis , Spermine/chemistry , Administration, Inhalation , Animals , Cell Line , Cell Survival , Chemical Phenomena , Genetic Therapy/methods , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Lung/metabolism , Lung/pathology , Male , Mice , Mice, Inbred C57BL , Nanoparticles/chemistry , Nanoparticles/toxicity , Plasmids/chemistry , Polymers/chemistry , Polymers/toxicity , Random Allocation , Toxicity Tests
16.
J Vet Med Sci ; 72(9): 1225-7, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20424392

ABSTRACT

The aim of this study was to develop in situ hybridization for detection of Mycoplasma hyorhinis in formalin-fixed, paraffin-wax-embedded tissues from pigs with polyserositis. M. hyorhinis was isolated from the spleen (2 pigs) and pericardium (1 pig). M. hyorhinis DNA was detected 16 out of 20 pigs with polyserositis. In situ hybridization produced a distinct positive signal for the M. hyorhinis p37 gene in inflammatory cells in the polyserositis. In situ hybridization developed in the present study present diagnostic tools capable of detection of M. hyorhinis in formalin-fixed, paraffin-wax-embedded tissues from the naturally infected pigs.


Subject(s)
Mycoplasma Infections/veterinary , Mycoplasma hyorhinis/isolation & purification , Serositis/veterinary , Swine Diseases/microbiology , Animals , Base Pairing , DNA Primers , DNA, Bacterial/isolation & purification , Heart/microbiology , In Situ Hybridization/veterinary , Mycoplasma Infections/diagnosis , Mycoplasma hyorhinis/genetics , Polymerase Chain Reaction , Serositis/microbiology , Swine , Swine Diseases/diagnosis
17.
J Vet Diagn Invest ; 22(2): 231-3, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20224081

ABSTRACT

The aim of the current study was to develop a nonradioactive in situ hybridization assay that can differentiate between genotypes 2a and 2b of Porcine circovirus-2 (PCV-2) in formalin-fixed, paraffin-embedded lymph node tissues from pigs with postweaning multisystemic wasting syndrome. Two different digoxigenin-labeled oligonucleotide probes were designed from the PCV-2 open reading frame 2 sequences. The PCV-2a-specific probe did not hybridize with formalin-fixed, paraffin-embedded lymph nodes from naturally PCV-2b-infected pigs and vice versa. Both PCV-2a-specific and PCV-2b-specific probes gave consistent negative signals in lymph nodes from naturally PCV-1-infected pigs. The in situ hybridization assay described in the present study represents a diagnostic tool that can differentiate between the 2 genotypes of PCV-2.


Subject(s)
Circovirus/classification , Circovirus/genetics , Formaldehyde/chemistry , In Situ Hybridization/veterinary , Paraffin Embedding/veterinary , Porcine Postweaning Multisystemic Wasting Syndrome/virology , Tissue Fixation/veterinary , Animals , Circovirus/isolation & purification , Genotype , In Situ Hybridization/methods , Swine
18.
PLoS One ; 5(12): e15623, 2010 Dec 22.
Article in English | MEDLINE | ID: mdl-21203518

ABSTRACT

BACKGROUND: Metastasis to the lung may be the final step in the breast cancer-related morbidity. Conventional therapies such as chemotherapy and surgery are somewhat successful, however, metastasis-related breast cancer morbidity remains high. Thus, a novel approach to prevent breast tumor metastasis is needed. METHODOLOGY/PRINCIPAL FINDING: Aerosol of lentivirus-based small hairpin osteopontin was delivered into mice with breast cancer twice a week for 1 or 2 months using a nose-only inhalation system. The effects of small hairpin osteopontin on breast cancer metastasis to the lung were evaluated using near infrared imaging as well as diverse molecular techniques. Aerosol-delivered small hairpin osteopontin significantly decreased the expression level of osteopontin and altered the expression of several important metastasis-related proteins in our murine breast cancer model. CONCLUSION/SIGNIFICANCE: Aerosol-delivered small hairpin osteopontin blocked breast cancer metastasis. Our results showed that noninvasive targeting of pulmonary osteopontin or other specific genes responsible for cancer metastasis could be used as an effective therapeutic regimen for the treatment of metastatic epithelial tumors.


Subject(s)
Aerosols , Gene Transfer Techniques , Lung Neoplasms/genetics , Lung Neoplasms/secondary , Mammary Neoplasms, Animal/pathology , Osteopontin/genetics , Animals , Cell Line, Tumor , Female , Humans , Lentivirus/genetics , Lentivirus/metabolism , Mice , Mice, Inbred BALB C , Neoplasm Metastasis , Osteopontin/biosynthesis , Osteopontin/metabolism , Skin Neoplasms/pathology , Treatment Outcome
19.
Can J Vet Res ; 74(4): 314-6, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21197232

ABSTRACT

The objective of this study was to determine the capsular serotypes and potential virulence factors of Streptococcus suis isolated from pigs with polyserositis. Among the 24 isolates evaluated, serotype 3 [7 (29%) of the isolates] and serotype 4 [5 (21%)] were the most common. The isolates were also studied for the presence of the genes mrp, epf, and sly, which encode muramidase-released protein (MRP), extracellular factor (EF), and suilysin (SLY), respectively. Of the 24 isolates, 8 carried mrp: 4 of serotype 3, 2 of serotype 2, and 2 of serotype 4. One mrp(+) isolate (serotype 2) also carried the epf gene. All 24 isolates carried the sly gene. The serotype and genotype distribution greatly differed from that reported for isolates from pigs with other clinical manifestations of S. suis infection in other countries.


Subject(s)
Bacterial Capsules/metabolism , Serositis/veterinary , Streptococcal Infections/veterinary , Streptococcus suis/pathogenicity , Swine Diseases/microbiology , Agglutination Tests/veterinary , Animals , Antigens, Bacterial/genetics , Antigens, Bacterial/metabolism , Bacterial Capsules/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Hemolysin Proteins/genetics , Hemolysin Proteins/metabolism , Polymerase Chain Reaction/veterinary , Serositis/microbiology , Serotyping/veterinary , Streptococcal Infections/immunology , Streptococcal Infections/microbiology , Streptococcus suis/genetics , Swine , Swine Diseases/immunology , Virulence
20.
Res Vet Sci ; 88(2): 304-6, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19767042

ABSTRACT

We investigated the localization of porcine reproductive and respiratory syndrome virus (PRRSV) in the mammary glands of experimentally infected sows using reverse transcription PCR and immunohistochemistry. Six pregnant sows were inoculated intranasally with PRRSV three weeks prior to the predicted farrowing date. The six PRRSV-infected sows and two uninfected negative control sows remained clinically healthy and farrowed normally. Milk samples were collected from all sows on lactation days 1, 2, and 3. PRRSV was detected in milk as early as lactation day 1 in all of the PRRSV-infected sows, but not in the uninfected sows. PRRSV antigen was detected by immunohistochemistry in macrophage-like cells in the alveolar lumina of the mammary glands and in other tissues. Our results show that PRRSV is shed in the milk of infected sows, and that PRRSV antigen is present in the mammary glands of experimentally infected sows.


Subject(s)
Mammary Glands, Animal/virology , Porcine respiratory and reproductive syndrome virus/physiology , Swine Diseases/virology , Animals , Female , Immunohistochemistry , Infectious Disease Transmission, Vertical/veterinary , Lactation , Milk/virology , Porcine Reproductive and Respiratory Syndrome/transmission , Porcine Reproductive and Respiratory Syndrome/virology , Pregnancy , Reverse Transcriptase Polymerase Chain Reaction , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...